| INTRODUCTION
Considerable epidemiologic evidence has indicated that a higher resting heart rate is a risk factor for arterial cardiovascular diseases, total mortality, higher blood pressure, lower physical fitness, and higher inflammatory markers in the general population. [1] [2] [3] [4] [5] Yet, to our knowledge, only the prospective Multi-Ethnic Study of Atherosclerosis (MESA) has examined whether higher resting heart rate is a risk factor for venous thromboembolism (VTE-deep vein thrombosis [DVT] or pulmonary embolism [PE] ).
6 MESA participants with a resting heart rate ≥80 beats per minutes (bpm) had double the risk of hospitalized VTE-as documented via discharge codes-compared to participants with a heart rate <60 bpm.
6
Possible mechanisms for a positive association of heart rate with VTE are speculative, but according to Virchow's triad should operate via hypercoagulability, venous injury, or venous stasis. Higher heart rate is correlated positively with multiple plasma inflammatory markers, like interleukin-6, C-reactive protein, and fibrinogen 5, 7 ; inflammatory processes could contribute to hypercoagulability by upregulating tissue factor 8 or by causing venous injury or insufficiency. 9, 10 Higher heart rate also typically reflects excessive sympathetic to parasympathetic activity, which might also contribute to venous injury or hypercoagulability. Conversely, it seems unlikely that a higher heart rate would increase the venous stasis component of Virchow's triad.
In contrast, it may be that the MESA association is artifactual, due to residual confounding from low physical fitness, the metabolic syndrome, or other unmeasured variables that might increase VTE risk.
We therefore sought to verify whether higher resting heart rate is a VTE risk factor in another prospective epidemiologic cohort, the Atherosclerosis Risk in Communities (ARIC) Study. Importantly, the ARIC Study, unlike MESA, has validated VTE outcomes. As a secondary analysis, we also examined whether another measure of sympathetic to parasympathetic activity-lower heart rate variability (HRV)-might also be a risk factor for VTE.
| METHODS

| Study sample and design
Previous publications described the overall ARIC study design, methods, and VTE incidence rates in detail. 11, 12 Briefly, 15 792 pre- 
| Measurements of heart rate and HRV
At Visit 1 and subsequent visits, ARIC performed a standard supine 12-lead electrocardiogram (ECG) and calculated resting heart rate as the mean RR interval of successive heart beats. Participants took their medications as usual on the morning of each visit. They rested supine on the examination table while ARIC staff placed the electrodes and then for 2 to 3 additional minutes before the ECG was taken. Our initial focus was on Visit 1, but because associations differed markedly from MESA, 6 we sought replication using ARIC Visit 4. We also picked Visit 4 because Visits 2 and 3 were too close to Visit 1, Visit 4 best matched the years of MESA and also had HRV data, and there have been too few VTEs so far after Visit 5. ARIC also recorded at Visit 1 a 2-minute ECG rhythm strip to assess short-term daytime HRV, as described elsewhere 13 and following published guidelines.
14 At Visit 4, ARIC obtained a 6-minute rhythm strip and derived identical HRV indices
15
: 2 time-domain HRV measures directly from heart rate or the duration between successive RR intervals: (1) the standard deviation of all normal-to-normal RR intervals, which characterizes overall HRV; and (2) the root mean square of successive differences in normal-to-normal RR intervals, which is thought to reflect parasympathetic nervous system activity. The HRV analysts also calculated three frequencydomain measures from spectral imaging of the ECG recording: (1) low-frequency (LF), power (0.04-0.15 Hz), considered to include both sympathetic and parasympathetic activities; (2) high-frequency (HF) power (0.15-0.40 Hz), thought to reflect parasympathetic activity; and (3) low-and high-frequency (LF/HF) power ratio, which estimates the balance between sympathetic and parasympathetic activity. Previous publications have described the validity and reliability of short-duration HRV metrics. 16, 17 For this report, we used Visit 4 HRV data.
| Other measurements
We measured other potential VTE risk factors at Visit 1 and Visit 4, 
Essentials
• Higher resting heart rate may be associated with increased risk of venous thromboembolism (VTE).
• We tested this hypothesis in a prospective population-based cohort followed nearly 2 decades.
• VTE incidence showed a dose-response with heart rate: 1.44-fold higher risk for ≥80 versus <60.
• Why high heart rate is a risk marker for VTE warrants further exploration. calcium channel blockers, digoxin, or amiodarone). Staff also assessed sports physical activity using the 
| Statistical analysis
We used 2 follow-up time frames for analyses: (1 we also examined heart rate at all 4 visits as a time-dependent variable.
We categorized resting heart rate as ≤60, 60 to 69, 70 to 79, or ≥80 bpm, as done in MESA, 6 and compared participant characteristics (means or frequencies) across these categories to identify possible confounding variables. We plotted Kaplan-Meier and restricted cubic spline curves to illustrate the cumulative incidence of VTE by heart rate categories. Using Cox proportional hazards models, we estimated the hazard ratios of VTE by resting heart rate categories and per 10 bpm of continuous heart rate. We also separately analyzed DVT vs. PE and provoked versus unprovoked VTE; hazard ratios for VTE unrelated to cancer were almost identical to those for unprovoked and thus not shown separately. We tested the proportional hazard assumption for heart rate, using an interaction term between heart rate and time and the examination of Schoenfeld residuals and log(−log) survival curves and found the assumption to be valid. Cox
Model 1 adjusted for age, race (black, white), and sex (after verifying no multiplicative interaction between heart rate and age, race, or sex at P > 0.01, because of multiple testing). Model 2 additionally adjusted for BMI, diabetes status (yes/no), current cigarette smoking status (yes/no), sports physical activity score, AV nodal blocking medication (yes/no), CKD status (yes/no), systolic blood pressure, antihypertensive medication use (yes/no), von Willebrand factor, and factor VIII. To examine for effect modification by VTE genetic risk, we tested the interaction between continuous heart rate and the weighted VTE genetic risk score. As a supplemental analysis, we also calculated hazard ratios after excluding participants with atrial fibrillation or AV nodal blocking medication.
Finally, Model 3 started with Model 2 and adjusted (separately) for the 5 natural log transformed HRV indices to determine (1) whether Visit 4 HRV might independently be associated with VTE and (2) whether Visit HRV potentially could explain any observed association of Visit 4 resting heart rate with VTE.
| RESULTS
| Descriptive information
Among the included 14 914 ARIC participants (54.8% female, 26.0% black) aged 45 to 64 and free of VTE at Visit 1 in 1987-1989, the mean resting heart rate was 66.7 bpm (SD = 10). Among participants attending at least 1 of the next 4 ARIC visits through 2011-2013, mean heart rate declined slightly-66, 66, 63, and 63 bpm, respectively.
The age-, sex-, and race-adjusted Pearson correlation between Visit 1 heart rate and Visit 4 heart rate was r = 0.53, whereas the correlation for Visit 1 vs. Visit 5, spanning nearly 2.5 decades, was r = 0.36, suggesting only moderate resting heart rate tracking over time.
The mean age of participants was 54 at Visit 1 and 63 years at Visit 4. As shown in Table 1 , Visit 1 resting heart rate was higher in women than in men and associated positively with BMI, systolic blood pressure, and prevalences of diabetes and CKD; heart rate was inversely associated with sports physical activity and AV nodal blocking medication. Visit 1 heart rate was associated positively with plasma factor VIII and von Willebrand factor concentrations, but heart rate was not associated with the genetic risk score for VTE. Most of these associations were similar at Visit 4, but by Visit 4, blacks and current smokers had higher heart rates than did whites and nonsmokers, and those in the highest heart rate category had a lower genetic risk score for VTE than did other categories. More notably, AV nodal blocking medications and risk factors were more common at Visit 4 than at Visit 1.
| Association of Visit 1 resting heart rate with incident VTE
Over a median of 26 years of follow-up (maximum 29 years), from Visit 1 through 2015, we identified 882 incident VTE events (446 PE, 436
DVT only). Visit 1 heart rate was not associated with VTE incidence (Table 2) . After adjusting for confounding variables ( Table 2 , Model 2), for each 10 bpm greater heart rate at Visit 1 the hazard ratio (95% CI) of VTE was 0.96 (0.90-1.03). There also was no association of Visit 1 heart rate with PE or with DVT only, or with provoked or unprovoked VTE.
| Association of Visit 4 resting heart rate with incident VTE
In contrast with the Visit 1 heart rate, the Visit 4 (1996 Visit 4 ( -1998 heart rate was positively and statistically significant associated with incident VTE (Figures 1 and 2 ). These findings were based on 557 incident VTE events (315 PE, 242 DVT only) over a median of 18 years of follow-up (maximum 20 years). As shown in [1987] [1988] [1989] and Visit 4 (1996 Visit 4 ( -1998 (Table S3 ). heart rate category ≥80 bpm compared with the <60 bpm category.
None of these associations were appreciably modified by age, sex, or race, nor was there an interaction between continuous heart rate and the VTE genetic risk score (P > 0.01 for all interaction tests).
| Association of Visit 4 HRV with incident VTE
As previously reported 22 , the 5 HRV indices we examined were moderately to highly correlated among themselves. All HRV indices except LF/HF were correlated negatively with heart rate (Pearson's r ranged from −0.10 to −0.53). As shown in Table 4 , most HRV indices were not significantly independently associated with VTE through 2015.
Furthermore, for the most part, the positive and significant association of Visit 4 heart rate with VTE persisted after adjustment for Visit 4 HRV indices ( Table 5 ), suggesting that lower HRV did not mediate the association between higher heart rate and increased incidence of VTE. Cumulative Incidence
TA B L E 2 Hazard ratios (95% CIs) of VTE by groups or 10 bpm increments of Visit 1 resting heart rate, ARIC, 1987-1989 through 2015
Resting heart rate (bpm) <60 
| DISCUSSION
This population-based cohort study found no independent association of ARIC Visit 1 resting heart rate or variability in heart rate with incident VTE, but it did find a positive and moderately strong graded association of Visit 4 resting heart rate with incident VTE (adjusted hazard ratio of 1.44 for the highest vs. lowest category of heart rate).
Our contrasting findings by ARIC visit may be due to differences in both cohort age (45-64 years at Visit 1 vs. 54-73 years at Visit 4) and median follow-up time for VTE (26 vs. 18 years). Heart rate declines on average with age. Between-person differences in resting heart rate may be more random in middle age, but more influenced in older age by the presence or absence of medical conditions contributing to VTE (partly illustrated in Table 1 ). The fact that heart rate at Visit 1 was only moderately correlated with heart rates at Visits 4 and 5 further suggests that resting heart rate does not track particularly well. Any single heart rate measurement might also not reflect heart rate throughout the day or week. A study of 75 chronic heart failure patients showed that resting heart rate correlated 0.76 with mean 1-day heart rate and 0.73 with TA B L E 4 Hazard ratios (95% CIs) of VTE by quartiles or per 1 standard deviation (SD) decrease of Visit 4 heart rate variability indices, ARIC, 1996-1998 through 2015
Heart rate variability indices mean 7-day heart rate. 23 Another consideration is that the majority of incident VTEs happened in the last decade of ARIC follow-up. Thus, our early follow-up of middle-aged participants after Visit 1 may be irrelevant to the vast majority of VTEs happening 2 decades later in the elderly. In addition, hospital diagnostic methods for the earlier VTEs captured by ARIC were sometimes less accurate than later ones-that is, Doppler ultrasound rather than duplex imaging for DVT, and ventilation-perfusion scans rather than computed tomography for PE.
A positive association of heart rate in Visit 4 with VTE is consistent in direction but weaker in magnitude with seemingly the only prior report on this topic, that from MESA. 6 MESA reported a 2-fold higher incidence rate of VTE in the highest vs. lowest category of heart rate, 6 which contrasts with the 1.44-fold gradient for ARIC. The mean age of the MESA cohort at baseline (62 years) was similar to the mean age of the ARIC cohort at Visit 4 (63 years). Yet ARIC methods for VTE ascertainment differed from MESA in an important way-ARIC physicians reviewed hospital records to identify VTE, whereas MESA used unvalidated hospital discharge ICD codes. An early ARIC publication reported a considerable disagreement rate between ICD codes and physician classification of VTE. 12 Other cohort studies of VTE likely have heart rate information and could help clarify whether there is any association between resting heart rate and VTE and whether it is age dependent.
As outlined in the Introduction, an association between high heart rate and increased VTE risk might reflect a causal relation-operating via high heart rate causing generalized inflammation, leading to VTE through hypercoagulability or venous injury. Against a causal role, a
Mendelian randomization study showed that a polygenetic risk score for heart rate was not associated with VTE risk in the general population. 24 We speculate that the positive association of heart rate with VTE is less likely to be a direct cause-and-effect than an indirect relation. For example, high heart rate may merely reflect underlying medical conditions, low physical fitness, the metabolic syndrome, or other risk factors (Table 1) , which could predispose to or trigger VTE. However, the post-Visit 4 association did persist after adjusting for a number of risk factors for VTE in this cohort, such as age, race, obesity, diabetes, and physical inactivity. Atherosclerotic cardiovascular diseases should not have confounded the heart rate-VTE association, as they have not been associated with increased risk of VTE in ARIC.
We also tested the hypothesis that HRV might be associated inversely with VTE incidence, first because HRV indices, like heart rate, reflect sympathetic to parasympathetic balance of the cardiac pacemaker tissues, and second because resting heart rate is moderately and inversely correlated HRV. HRV proved mostly unassociated with incident VTE. When we adjusted for HRV indices, the association between heart rate and VTE persisted, suggesting HRV was not a mediator of the association.
A study limitation not already mentioned is that ARIC identified hospitalized VTE patients only, as did MESA. Thus, our VTE case definition should be highly specific but somewhat insensitive. The omission of outpatient VTEs could have led to biased hazard ratios, but the bias would be most severe if proportion of missed VTEs differed by heart rate; this seems unlikely.
In conclusion, we found a significant positive and independent association of resting heart rate at ARIC Visit 4 with incidence of VTE.
We found no strong association of HRV with VTE. The reason why high heart rate is a risk marker for VTE warrants further exploration.
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TA B L E 5
Hazard ratios (95% CIs) of VTE by groups or 10 bpm increments of Visit 4 resting heart rate, adjusting for Visit 4 HRV indices, ARIC, 1996-1998 through 2015
Resting heart rate (bpm) <60 Abbreviations: ARIC, Atherosclerosis Risk in Communities; bpm, beats per minute; CI, confidence interval; HF, high frequency; HR, hazard ratio; HRV, heart rate variability; LF, low frequency; VTE, venous thromboembolism.
